Scholars Central

Review articlePublished 30 Jul 2022

Usage of MicroRNA in Potential Therapeutics of Ewing’s Sarcoma

Authors: Irena Boulytcheva

Department of Medicine, Blokhin Russian Cancer Research Center, Russia

Journal of Orthopedic Oncology

Volume 8 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

MicroRNAs (miRs) have recently emerged as important regulators of intracellular gene expression. In miR, which is often dysregulated in cancer, sheds new light on the molecular mechanisms of carcinogenesis and is of great interest as a biomarker and new therapies and targets. Recently, many studies have investigated the miR biology of Ewing sarcoma. The results indicate that changes in miR expression are widespread in Ewing sarcoma, including both carcinogenic EWS / Ets fusion-dependent and independent mechanisms, and contribute to a malignant phenotype.MiRs with potential prognosis have been identified, and several preclinical studies suggest that miR manipulation may be therapeutically useful for this invasive disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Orthopedic Oncology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Orthopedic Oncology
  • SubjectOncology & Cancer
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “Irena Boulytcheva”